Pulbo 801 mg (Tablet)
Unit Price: ৳ 125.00 (1 x 10: ৳ 1,250.00)
Strip Price: ৳ 1,250.00
Medicine Details
Category | Details |
---|---|
Generic | Pirfenidone |
Company | Opsonin pharma ltd |
Also available as |
Indications
- Treatment of mild to moderate Idiopathic Pulmonary Fibrosis (IPF)
Pharmacology
- Anti-inflammatory properties
- Antioxidant properties
- Anti-fibrotic properties
- Improvement of lung function
- Reduction of acute exacerbations in patients with IPF
- Suppression of TGF-β1
- Downregulation of pro-inflammatory cytokines
- Inhibition of inflammatory cell influx
- Inhibition of increased pulmonary vascular permeability
Dosage & Administration
- Oral route of administration
- Titration of dose over a 14-day period
- Recommended daily dose of three 267 mg tablets or one 801 mg tablet three times a day with food
- Dose adjustments for gastrointestinal events
- Dose adjustments for photosensitivity reaction or rash
- Dose adjustments for hepatic function
- Resumption of dose after treatment interruption
- Recommendation for missed doses
Interaction
- Moderate and strong CYP1A2 inhibitors interaction
- Effect of food on reducing adverse reactions
Contraindications
- Hypersensitivity to the active substance or excipients
- Concomitant use of fluvoxamine
- Severe hepatic impairment
- End-stage liver disease
- Severe renal impairment or end-stage renal disease requiring dialysis
Side Effects
- Common side effects: nausea, rash, abdominal pain, upper respiratory tract infection, diarrhea, fatigue, headache, dyspepsia, dizziness, vomiting, anorexia, gastroesophageal reflux disease, sinusitis, insomnia, weight decrease, arthralgia
- Rare side effects: photosensitivity reaction, decreased appetite, pruritus, asthenia, dysgeusia, non-cardiac chest pain
Pregnancy & Lactation
- Precaution to avoid use during pregnancy
- Unknown excretion in human milk
- Risk to the suckling child
- Effect on fertility
Precautions & Warnings
- Elevated liver enzymes monitoring
- Photosensitivity and rash precautions
- Gastrointestinal disorders precautions
Use in Special Populations
- Safety and efficacy in children & adolescents unknown
- Monitoring and dosage modification for hepatic impairment
- Monitoring and dosage modification for renal impairment
- Altered exposure in smokers
Overdose Effects
- Limited clinical experience with overdose
- Mild, transient adverse reactions
Therapeutic Class
- Immunosuppressant
Storage Conditions
- Cool and dry storage
- Protection from light and moisture
- Keep out of reach of children
Related Brands
- Pulmosis 267 mg (Capsule) - incepta-pharmaceuticals-ltd
- Pulfibro 267 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Pulfibro 801 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Pulfibro 534 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Pulmosis 801 mg (Tablet) - incepta-pharmaceuticals-ltd